Introduction
Chronic myeloid leukaemia (CML), the commonest type ofleukaemia in India, usually presents with considerable splenomegaly, high leucocyte count, low leucocyte alkaline phosphatase (LAP) score and the presence of Philadelphia (Ph + ) chromosomal abnormality. Absence of splenomegaly occurs in less than 5% of patients.' Similarly there are very few reports of spontaneous cyclic oscillations of the leucocyte counts in these patients.2-7 In this communication, we present a patient who had these two unusual features during the initial phase of his illness.
Case report
A 54 year old male presented to us in September 1988 with a history of pain and swelling in the left leg and large red and blue ecchymotic patches over the shoulder, hips and thighs of 16 days duration. He was known to have uncomplicated ischaemic heart disease and non-insulin dependent diabetes mellitus.
Physical examination revealed a few ecchymotic patches over the extremities and evidence of deep vein thrombosis in the left leg. The rest of the physical examination was unremarkable. There was no splenomegaly or bone tenderness. Haematological profile revealed a haemoglobin level of 11.5 g/dl, total leucocyte count 148 x 109/l with neutrophils 60%, stab forms 15%, metamyelocytes 10%, myelocytes 5%, monocytes 5% and lymphocytes 5%. In view of these findings, his age, absence ofsplenomegaly, and presence ofdeep vein thrombosis, he was considered to have either leukaemoid reaction secondary to a possible underlying malignancy or CML. The latter diagnosis was subsequently confirmed on the basis of low LAP score (LAP score of patient = 2, control = 60) and the presence of Ph + chromosome.
He was followed up with or without therapy and subsequent haematological findings, reflected in Figure 1 , showed the interesting phenomenon of spontaneous oscillations of leucocyte counts. He maintained high leucocyte counts for a period of 50 to 60 days interrupted by a period of normal leucocyte counts for a period of 20 to 30 days. Haemoglobin levels also showed similar fluctuations ( Figure 1 ). Platelets were not counted but were found to be adequate on the basis of peripheral blood film examination. It is evident that treatment with busulphan either alone or with hydroxyurea did not modify the cyclic pattern of the leucocyte counts or the haemoglobin levels.
In July 1989 there was a sudden transformation of the chronic phase of CML into acute lymphoblastic leukaemia. There was no intervening evidence of accelerated phase of the disease. At the time of blast crisis the total leucocyte count was 16.8 x 109/l with 40% blasts present in the peripheral smear. There was no splenomegaly. He had a temporary remission with vincristine and prednisolone combination therapy before he relapsed and died in November, 1989.
Discussion
The leucocyte count usually rises exponentially in patients of CML. However, some of these patients are reported to have periodic fluctuations of the leucocyte counts with or without therapy.27 The oscillation of leucocyte counts with shorter intervals and lower amplitude has long been observed in some healthy individuals.8 It has therefore been suggested that the granulocyte production by the bone marrow is cyclical, being controlled by a negative feed back circuit and is not due to any selective shifting between the circulating and the marginating leucocyte pools. 4 The negative feed back control is believed to be exerted by colony stimulating factor.2'4'7'9 Periodic fluctuations in the reticulocyte and platelet counts have also been described.247 Our patient also showed periodic variations of the haemoglobin levels in phase with the leucocyte counts. Furthermore similar patterns of cyclic oscillations of the leucocyte counts were maintained with or without therapy. These observations suggest that CML may not always be an autonomous neoplasm with unrestrained cellular growth. Rather, a feed back control mechanism, though partial, may possibly be retained in some of these patients. Another interesting feature observed in our patient was the absence of splenomegaly at the onset of the disease. This is not a common finding, being usually reported in less than 5% of patients of CML.' Besides the conventional treatment, other therapeutic options exist for such patients. It may be possible to control the high leucocyte count by means of leucapheresis or by suitably modifying the feed back mechanism(s). The findings in our patient reinforce the need to study the natural history and pathophysiology of the disease in greater detail particularly the feed back control mechanism(s). Such studies may lead to the development of suitable therapeutic interventions with the ultimate objective of curing this largely fatal condition. 
